已发表SCI文章

2018.12.05
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

1.jpg2.jpg3.jpg4.jpg5.jpg6.jpg7.jpg8.jpg9.jpg10.jpg

注：图片均来源于Nature Communications

  返    回
Characterization of Hyperprogression After Immunotherapy in a Lung Adenocarcinoma Patient With Strong Expression of Programmed Death Ligand 1
Clinical Outcome and Molecular Analysis of a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Mutation V834L